Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis.
AffiliationDepartment of Medicine, St. Columcilles Hospital, Loughlinstown, Co. Dublin, Ireland. email@example.com
Receptors, Tumor Necrosis Factor
Severity of Illness Index
MetadataShow full item record
CitationPneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis. 2007, 176 (4):309-11 Ir J Med Sci
JournalIrish journal of medical science
AbstractPneumocystis carinii pneumonia (PCP) is a rare form of pneumonia associated with immune-suppression. It is common in patients with AIDS and with a CD4 count of less than 200 cells/mm(3). We report a case of PCP secondary to immune-suppression in a 41-year-old man with psoriatic arthritis being treated with the immune-modulatory agent etanercept.
Diagnosis of PCP was made histologically using tissue obtained via transbronchial biopsy.
There was a good response to standard treatment with high-dose co-trimoxazole.
This report highlights a recognised but previously unreported complication of etanercept.